MedPath

The efficacy and safety of trans-catheter embolization for inferior mesenteric artery and lumbar artery to prevent persistent type 2 endoleak prior to endovascular abdominal aortic aneurysm repair (EVAR) with Excluder stent-graft:multicenter prospective study

Phase 1
Conditions
Abdominal aortic aneurysm
Registration Number
JPRN-UMIN000031059
Lead Sponsor
Department of Radiology, Kobe University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Rupture case The severe stenosis or occlusion of superior mesenteric artery The bilateral occlusion of internal iliac artery Uncontrollable of heart failure, angina pectoris, and arrhythmia despite of treatment Concomitant with active cancer Sever drug allergy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The incidence of EL2 after EVAR in 6 months
Secondary Outcome Measures
NameTimeMethod
The incidence of EL2 after EVAR in 1 year Technical success rate of IMA/LA embolization Safety of IMA/LA embolization Aneurysm diameter after EVAR within 30days, 6 month and 1 year Aneurysm related death after EVAR within 30days, 6 month and 1 year Re-intervention rate for EL2 after EVAR within 30days, 6 month and 1 year
© Copyright 2025. All Rights Reserved by MedPath